Top 10 Telehealth Apps in 2026: Features, Pricing & What to Copy

At Make An App Like, we have built and shipped 20+ production clone apps across streaming, marketplaces, mobility, and AI — which means we read a healthtech category the way an operator does, not the way a press release does. In this list, we rank the top 10 telehealth apps in 2026 — their features, pricing, ideal user, monetization model, and where each one shines or stalls. Every call below is grounded in how these platforms actually behave under regulatory load, provider-network strain, and real subscriber churn.

Telehealth stopped being a pandemic novelty years ago. In 2026 it is a mature, contested category where consumer DTC brands, payer-owned platforms, and enterprise SaaS vendors fight over the same visit. If you are researching this space to study it, benchmark against it, or build a competitor, this is the map.

The Telehealth Landscape: A 2026 Snapshot

Telehealth in 2026 is one of the fastest-compounding segments in digital health, pulled forward by clinician shortages, asynchronous care, and the GLP-1 prescribing boom. The category now spans everything from urgent-care video visits to always-on chronic-condition management.

As per Grand View Research, the global telehealth market is estimated to reach roughly $285 billion by 2026, expanding at a CAGR near 24% through 2030 as virtual-first care becomes a default rather than a fallback. That growth is uneven — reimbursement policy, state licensure, and pharmacy economics decide which apps actually convert visits into durable revenue.

The category is currently dominated by Teladoc Health, Amwell, and Hims & Hers, with Ro and payer-owned platforms like MDLIVE rounding out the top tier in the US. Consumer DTC brands are winning on acquisition and brand, while enterprise platforms win on payer and employer contracts — two very different games under one label.

Anyone evaluating this space in 2026 needs a ranking that separates download charts from unit economics. The apps that look biggest are not always the ones worth copying. The methodology below explains exactly how we weighted the field.

Selection Methodology

We built this ranking around measurable outcomes — reach, revenue durability, clinical breadth, and the defensibility of the underlying model — rather than marketing spend or funding headlines. Each app was scored against the same objective criteria so a payer platform and a DTC brand could be compared on the same axis.

• User base and reach — members, monthly active patients, and completed visits reported through 2025-2026.
• Revenue and growth rate — top-line scale, retention, and whether growth is subsidised or self-funding.
• App-store ratings — weighted iOS and Google Play scores as a proxy for real patient experience.
• Feature depth and platform coverage — video, async chat, e-prescribing, EHR integration, and web plus mobile parity.
• Geographic and licensure footprint — state coverage, provider network size, and international reach.
• Category-defining innovation — AI triage, pharmacy verticalization, or employer distribution that others copy.

This ranking is opinionated. A hospital CIO, a DTC founder, and a growth PM will each weight these factors differently — and they should. We respect that judgement; treat our order as a considered starting point, not a verdict.

Top 10 Telehealth Apps Ranked for 2026

Below is the ranked field. Entry #1 is our top pick; the order reflects overall category strength, not alphabet or funding. Each entry covers what the app is, its features, pricing, ideal user, and an honest read on its ceiling.

1. Teladoc Health

Teladoc Health is the most established name in virtual care, operating across the US and internationally with tens of millions of members reached through employer and payer contracts. Its footprint spans general medical, mental health (via BetterHelp), and chronic-condition management (via the Livongo acquisition). With annual revenue in the multi-billion-dollar range, it remains the reference point for enterprise telehealth scale.

• Whole-person platform — combines urgent care, primary care, mental health, and chronic care in one stack.
• Chronic-condition programs — connected devices for diabetes and hypertension via the Livongo engine.
• Employer & payer distribution — sold through benefits channels rather than pure DTC acquisition.
• Global provider network — licensed clinicians across dozens of countries and specialties.
• Integrated behavioral health — BetterHelp gives it the largest virtual therapy footprint in the category.

Pricing: Mostly covered via employer/insurance; direct visits from about $0 to $89 depending on plan and service line.

Best For: Enterprises, health plans, and employers wanting a single whole-person virtual-care vendor.

Teladoc's signature strength is breadth — few platforms cover urgent, chronic, and mental health at this scale under one contract. Its biggest limitation is that breadth: integrating acquisitions like Livongo and BetterHelp has weighed on margins and brand focus, and its DTC mental-health arm faces intense acquisition-cost pressure. Depth of distribution, not product novelty, is what keeps it on top.

2. Amwell

Amwell (American Well) is the enterprise-platform counterweight to Teladoc, positioning itself less as a consumer brand and more as the infrastructure health systems and payers run their own virtual care on. Its Converge platform is licensed to hospitals, insurers, and government programs, making it a white-label-style backbone rather than a destination app.

• Converge platform — a single technology layer for automated, video, and in-app care programs.
• Health-system embedding — powers branded virtual care inside hospital and payer apps.
• Automated care programs — digital modules for behavioral health and chronic conditions.
• Broad EHR integration — connects into major electronic health record systems.
• Device-agnostic delivery — kiosks, carts, mobile, and web for in-facility and remote care.

Pricing: Enterprise licensing and per-visit fees; consumer visits typically $79 to $99 where cash-pay.

Best For: Hospitals and payers that want to run virtual care under their own brand.

Amwell's strength is its platform posture — it sells the rails, letting institutions keep the patient relationship. Its limitation is that this same posture caps consumer mindshare and has made profitability elusive as it competes on enterprise sales cycles. For builders, it is the clearest proof that telehealth infrastructure itself is a sellable product.

3. Hims & Hers Health

Hims & Hers is the standout direct-to-consumer telehealth brand, built on lifestyle conditions — hair loss, sexual health, skincare, mental health, and weight management — and vertically integrated with its own pharmacy fulfillment. With more than two million subscribers and revenue that crossed the billion-dollar mark, it has proven that consumer telehealth can be a self-funding, brand-led business.

• Vertical pharmacy — owns fulfillment, capturing margin on prescription and OTC products.
• Subscription-first model — recurring monthly plans rather than one-off visits.
• Condition-specific funnels — tightly designed acquisition flows per category.
• Personalized compounding — custom formulations that lift retention and margin.
• Brand-led acquisition — consumer marketing that most healthtech companies cannot match.

Pricing: Subscription plans from about $20/mo to $200+/mo depending on condition and medication.

Best For: Consumers wanting discreet, recurring treatment for lifestyle and chronic conditions.

Its signature strength is the flywheel: brand plus owned pharmacy turns a visit into a recurring product subscription. The limitation is regulatory and reputational exposure — heavy reliance on compounded GLP-1 and lifestyle prescribing invites scrutiny, and any tightening of compounding rules directly pressures the model. For DTC builders, it is the most instructive template on this list.

4. Ro

Ro (formerly Roman) is Hims's closest DTC rival, a vertically integrated healthcare company spanning telehealth, diagnostics, and a national pharmacy. It has leaned hard into weight management and metabolic health, positioning itself as a longitudinal care provider rather than a single-condition storefront, with in-home lab draws and body-composition tracking layered on top.

• Owned pharmacy and labs — controls prescribing, fulfillment, and in-home diagnostics.
• Metabolic focus — a deep GLP-1 and weight-management care program.
• Longitudinal care model — ongoing monitoring rather than episodic visits.
• Provider network — nationwide licensed clinicians for async and synchronous care.
• Ro Mind & adjacent lines — expansion into mental health and primary care.

Pricing: Membership and treatment plans from roughly $15/mo to $135+/mo plus medication costs.

Best For: Consumers wanting integrated weight-management and metabolic care with home diagnostics.

Ro's strength is depth of vertical integration — owning labs and pharmacy lets it manage a condition end-to-end. Its limitation is concentration risk: like several DTC peers, a large share of momentum rides on the GLP-1 wave, which ties its trajectory to drug supply, pricing, and shifting compounding regulation. Diversification into primary care is the hedge to watch.

5. Included Health (Doctor On Demand)

Doctor On Demand, now part of Included Health, is a video-first virtual-care service that merged clinical care with a navigation layer that guides members to the right provider and benefit. It serves consumers directly and, increasingly, through employers and health plans, blending urgent care, primary care, and behavioral health with concierge-style guidance.

• Video-first visits — board-certified physicians and therapists on demand.
• Care navigation — Included Health's layer that routes members to covered, in-network care.
• Behavioral health — integrated therapy and psychiatry alongside medical visits.
• Employer distribution — sold as a benefit with cost-steering value for payers.
• Longitudinal primary care — ongoing relationships, not just one-off visits.

Pricing: Often employer-covered; cash-pay visits typically $75 to $299 by service line.

Best For: Employers wanting virtual care plus benefits navigation in one package.

The standout is the pairing of care with navigation — it does not just deliver a visit, it steers spend, which is what payers pay for. The limitation is brand ambiguity after the Included Health merger; consumers know the doctor visit better than the parent, and the value story is aimed at benefits buyers, not end users.

6. MDLIVE

MDLIVE, an Evernorth (Cigna) company, is a payer-owned telehealth platform delivering urgent care, primary care, dermatology, and behavioral health. Its advantage is distribution: as part of a major payer, it is embedded directly into insurance benefits for tens of millions of covered lives, making it a default virtual option for many members.

• Payer-embedded access — built into Cigna/Evernorth benefit designs.
• Multi-specialty coverage — urgent care, primary care, derm, and behavioral health.
• Async dermatology — photo-based skin evaluations with fast turnaround.
• Low-friction copays — often $0 or low cost for covered members.
• National provider network — licensed clinicians across all states.

Pricing: Frequently $0 to $82 per visit depending on plan; behavioral health priced higher.

Best For: Insured members wanting low-cost virtual visits inside their existing plan.

MDLIVE's strength is structural — payer ownership solves the acquisition problem that bleeds DTC competitors. Its limitation is dependence on that same parent: it is a feature of an insurance product more than a standalone brand, which caps independent growth and product ambition. It is the clearest case for why distribution beats app polish in this category.

7. Sesame

Sesame is a cash-pay healthcare marketplace that lets patients book directly with providers at transparent, upfront prices — no insurance required. It connects consumers to virtual and in-person visits, prescriptions, labs, and even GLP-1 programs, functioning as an open marketplace rather than a closed provider network.

• Transparent cash pricing — flat, listed prices for every visit and service.
• Provider marketplace — independent clinicians list and compete on price.
• No-insurance model — built for the uninsured, underinsured, and cash-pay patients.
• Bundled services — visits, labs, imaging, and prescriptions in one checkout.
• Membership option — Sesame Plus discounts recurring care.

Pricing: Cash visits from about $25 to $99; Sesame Plus membership around $11/mo.

Best For: Cash-pay patients and builders studying a marketplace-model healthcare app.

Sesame's standout is pricing transparency in a system famous for the opposite — it turns healthcare into a browsable, comparable marketplace. Its limitation is the classic two-sided challenge: it must keep both quality providers and price-sensitive patients on the platform, and cash-pay volume is thinner than payer-fed channels. For builders, it is the most copyable structural model here.

8. Maven Clinic

Maven Clinic is the category leader in virtual women's and family health, covering fertility, maternity, menopause, and pediatric support. Sold primarily to employers and health plans, it has become one of digital health's most valuable private companies by owning a demographic that broad telehealth platforms serve only shallowly.

• Full reproductive-health journey — preconception, fertility, pregnancy, postpartum, and menopause.
• Care advocates — dedicated guides coordinating the member's care team.
• Global provider network — multilingual specialists across many countries.
• Employer benefit design — sold as a family-benefit that lowers payer costs.
• Wallet & payments — manages fertility and adoption benefit reimbursement.

Pricing: Employer-funded per-employee contracts; not a consumer cash-pay app.

Best For: Employers offering fertility, maternity, and family-health benefits.

Maven's strength is vertical focus — by owning women's and family health end-to-end, it defends a niche that horizontal platforms treat as an afterthought. Its limitation is channel dependence: it lives or dies on employer benefit budgets, which tighten in downturns, and it has little direct-to-consumer presence to fall back on. Focus is both its moat and its constraint.

9. K Health

K Health is an AI-first primary-care app that uses a symptom-checking chatbot trained on clinical data to triage patients before connecting them to a clinician. It has partnered with major health systems to blend algorithmic intake with human care, positioning AI as the front door to affordable primary and chronic-condition care.

• AI symptom triage — a data-trained assistant that narrows likely conditions before the visit.
• Text-based clinician care — async messaging plus scheduled visits.
• Chronic-care programs — subscription management for conditions like anxiety and hypertension.
• Health-system partnerships — co-branded care with hospital networks.
• Low-cost membership — flat monthly pricing undercutting traditional visits.

Pricing: Membership around $29/mo; one-off visits roughly $35 to $75.

Best For: Cost-conscious patients comfortable starting care with an AI intake.

K Health's standout is using AI to lower the marginal cost of triage, which is the single biggest lever in primary-care economics. Its limitation is trust and liability — patients and regulators scrutinise AI-assisted diagnosis closely, and clinical oversight has to scale alongside the model. It is the clearest signal of where AI is actually reshaping the category.

10. PlushCare

PlushCare, part of Accolade, is a subscription-based virtual primary-care service pairing members with a dedicated physician from top US medical centers. It focuses on ongoing primary care, mental health, and prescription management, with the option to keep the same doctor across visits — a continuity feature many urgent-care-style apps lack.

• Dedicated physician — members can keep one primary-care doctor over time.
• Primary and mental health — combined medical and behavioral care.
• Insurance accepted — works with many major plans plus cash-pay.
• Prescription management — ongoing refills and medication oversight.
• Same-day availability — fast booking for members.

Pricing: Membership about $17/mo plus visit fees around $99 (or copay with insurance).

Best For: Patients wanting continuity of care with a consistent virtual primary doctor.

PlushCare's strength is continuity — a real doctor relationship, not a rotating urgent-care queue, which drives retention. Its limitation is scale and differentiation: it competes against payer-backed and DTC giants with far larger acquisition budgets, and its continuity edge is easy to describe but hard to market against $0-copay alternatives. It rounds out the field as the primary-care-continuity play.

Telehealth Apps Compared at a Glance

This table compresses the ten deep dives above into a single quick-reference view. Rows follow the same ranking order; use it to shortlist, then return to the full entries for the trade-offs.

How to Choose the Right Telehealth App

The best telehealth app depends entirely on who you serve and how you get paid. A DTC founder, a benefits buyer, and a patient shopping for a doctor are optimizing for different things. Work through the criteria below before you shortlist.

Define Your Audience and Use Case

Start with the patient, not the feature list. Urgent one-off visits, chronic-condition management, behavioral health, and lifestyle prescribing each demand a different clinical model and retention strategy. A weight-management member needs longitudinal monitoring; an urgent-care user needs speed and availability. Map your primary use case first, because it dictates whether you need async messaging, connected devices, continuity of provider, or a broad on-demand network — and which app on this list is your real reference.

Evaluate the Pricing and Reimbursement Model

Telehealth economics split into three lanes: insurance-reimbursed, employer-funded, and cash-pay. Reimbursed and employer models solve acquisition but tie you to slow contracts and payer rules. Cash-pay and subscription models give pricing freedom but put customer acquisition cost squarely on you. Decide which lane your business lives in, because it shapes everything downstream — margin, marketing spend, and whether you resemble MDLIVE, Maven, or Hims. Mixing lanes is possible but multiplies operational complexity.

Check Platform Coverage and Integrations

Confirm full parity across iOS, Android, and web, plus the integrations that make care usable at scale. E-prescribing (Surescripts), lab and pharmacy connectivity, payment processing, and EHR interoperability are not nice-to-haves — they are the plumbing that turns a video call into completed care. Enterprise-facing platforms like Amwell live or die on EHR integration; DTC brands live or die on checkout and pharmacy fulfillment. Match the integration depth to your model before committing.

Verify Compliance and Clinical Governance

Healthcare is a regulated business first and an app second. Any serious telehealth product needs HIPAA-compliant data handling, state-by-state provider licensure, controlled-substance prescribing rules, and clinical oversight of protocols and AI. The apps that scaled did so by treating governance as core architecture, not an afterthought. If you are building, budget for compliance, medical directorship, and audit from day one — retrofitting it after launch is far costlier than designing for it.

Assess Scalability and Provider Network

Software scales instantly; licensed clinicians do not. The hardest constraint in telehealth is supplying enough credentialed, multi-state providers to meet demand without wait times collapsing the experience. Evaluate how a model sources, credentials, and retains clinicians — an owned W-2 network, a 1099 pool, or a marketplace like Sesame. Your growth ceiling is set by provider supply and licensure logistics far more than by app performance, so pressure-test that side of the marketplace early.

Trial the Top 2-3 Picks Before Committing

Whether you are buying a platform or benchmarking to build one, run real visits through your shortlisted apps. Book an actual appointment, test the intake flow, time the provider match, and check how prescriptions and follow-ups are handled. The gap between a polished landing page and a smooth completed visit is where most telehealth products fail. A weekend of hands-on trials will teach you more than any feature comparison — including this one.

Our Recommendation

No single telehealth app wins for everyone, because the category serves enterprises, consumers, and builders with opposite needs. Here is how we would pick depending on the job to be done.

Best Overall: Teladoc Health

For the broadest audience, Teladoc Health remains the reference platform. It covers urgent, primary, chronic, and behavioral health at a scale no rival matches, distributed through the employer and payer channels where telehealth demand is most durable. It is not the flashiest product, but for an organization that wants one whole-person virtual-care vendor with proven reach, it is still the safest institutional bet in 2026.

Best for DTC Consumer Health: Hims & Hers

If your goal is a direct-to-consumer telehealth brand, Hims & Hers is the template to study. Its combination of condition-specific funnels, subscription retention, and an owned pharmacy shows how to turn a single visit into a recurring product business that funds its own growth. Watch the regulatory exposure around compounded prescribing, but the core flywheel is the clearest playbook for consumer healthtech on this list.

Best for Builders Studying the Category: Sesame

For founders who want the most copyable structural model, Sesame is the one to reverse-engineer. Its transparent, cash-pay marketplace sidesteps insurance complexity and turns healthcare into a browsable, price-comparable experience. The two-sided marketplace mechanics — onboarding providers, listing flat prices, matching patients — map cleanly onto a buildable product, making it the most instructive blueprint for a lean, insurance-free telehealth launch.

How Do Telehealth Apps Make Money?

Telehealth monetization is more varied than most app categories because healthcare has three payers — patients, employers, and insurers — and the best businesses stack more than one. These are the dominant revenue models across the field.

Subscription and Membership

Recurring monthly plans are the backbone of consumer telehealth. Apps like Hims, Ro, K Health, and PlushCare charge a flat membership for ongoing access, refills, and monitoring. Subscriptions smooth revenue, lift lifetime value, and convert episodic care into a predictable relationship — the single most important lever for DTC unit economics. The trade-off is churn: members cancel once a condition resolves, so retention design is constant work.

Per-Visit and Cash-Pay Fees

The oldest model is fee-for-service: patients pay a flat, transparent price per visit. Sesame built its entire marketplace on this, and most platforms offer a cash-pay option for uninsured users. It is simple, honest, and easy to launch, but revenue is lumpy and tied directly to visit volume, so it rarely scales as cleanly as recurring subscriptions without a membership layer on top.

Employer and Payer Contracts

The largest telehealth revenue often comes from B2B2C deals — employers and health plans pay a per-member-per-month (PMPM) fee to offer virtual care as a benefit. Teladoc, Maven, MDLIVE, and Included Health lean heavily on this. It solves acquisition and produces durable, contracted revenue, but sales cycles are long, procurement is demanding, and budgets tighten in downturns. It is the model that funds category leaders.

Pharmacy and Prescription Fulfillment

Owning the pharmacy is where DTC telehealth captures real margin. Hims and Ro fill their own prescriptions, earning on the medication as well as the visit and compounding personalized formulations for extra value and stickiness. This vertical integration is the highest-margin lever available to consumer telehealth — but it also concentrates regulatory risk, particularly around compounded and controlled substances.

Insurance Reimbursement

Many platforms bill insurers directly for covered visits, collecting the reimbursed rate plus any copay. This unlocks the large insured population and lowers the price barrier for patients, but it drags in claims infrastructure, coding, prior authorization, and reimbursement-rate risk. Platforms like PlushCare and MDLIVE operate here. It is essential for mainstream primary care but adds meaningful operational and compliance overhead.

Platform and SaaS Licensing

Some companies sell the technology itself. Amwell licenses its Converge platform to hospitals and payers who run branded virtual care on top of it — a white-label, recurring-license model closer to enterprise SaaS than to a consumer app. Margins can be strong and revenue is contracted, but it demands enterprise sales muscle and deep EHR integration, and it cedes the direct patient relationship to the institution.

Build Your Own Telehealth App with Make An App Like

Make An App Like is a US-based development studio and white-label clone catalogue. Over the past three years, our team has shipped 20+ production clones across streaming, marketplaces, mobility, and AI companion products — the same architectural patterns that power a telehealth platform: real-time video, secure messaging, provider marketplaces, subscription billing, and payment rails at scale.

A ready-made telehealth build with our team ships in 14-30 days for roughly $4,500-$18,000, depending on scope. You get complete source code, deployed on your servers, branded as your platform — HIPAA-ready video visits, e-prescribing hooks, provider scheduling, cash-pay or subscription billing, and admin dashboards — instead of waiting 6-12 months for an in-house engineering team to assemble the same components from scratch.

The budget you would have spent on engineering goes into what actually differentiates a telehealth business: clinician recruitment, multi-state licensure, compliance and clinical governance, and patient acquisition. That is where the outcome in this category is decided — not in whether your video component renders, but in whether you can supply credentialed care faster and cheaper than the incumbents on this list.

Frequently Asked Questions

How are these telehealth apps ranked?

We ranked the field against consistent, objective criteria rather than marketing spend or funding: user base and reach, revenue durability and growth, weighted iOS and Google Play ratings, feature depth and platform coverage, geographic and licensure footprint, and category-defining innovation. We weighted defensibility heavily — whether a model self-funds and whether its distribution is durable. That is why payer-embedded and platform businesses rank alongside flashier DTC brands. The order reflects overall category strength for a B2B reader studying the space, but different readers should reweight the factors for their own use case.

Which is the best telehealth app for consumers?

For direct-to-consumer use, Hims & Hers leads on brand, breadth of lifestyle conditions, and a smooth subscription experience with owned pharmacy fulfillment. Ro is the closest alternative, especially for metabolic and weight-management care with home diagnostics. If you want the lowest-cost path and are insured, MDLIVE or a payer-embedded option may cost you $0. For transparent cash pricing without insurance, Sesame is the strongest pick. The right consumer app depends on your condition, whether you have coverage, and whether you value continuity of provider.

How much do telehealth apps make in 2026?

Revenue spans a wide range. Category leaders like Teladoc generate multi-billion-dollar annual revenue through employer and payer contracts, while fast-growing DTC brands such as Hims & Hers have crossed the billion-dollar mark on subscriptions and pharmacy sales. Smaller focused players earn tens to hundreds of millions. Overall, per Grand View Research the global telehealth market is estimated to reach around $285 billion by 2026, growing at a CAGR near 24% through 2030 — but individual app economics depend heavily on payer mix, retention, and whether the business owns pharmacy margin.

What monetization pattern dominates this category?

Two patterns dominate, split by audience. For enterprise-facing platforms, per-member-per-month employer and payer contracts produce the largest, most durable revenue — that is how Teladoc, Maven, and MDLIVE scale. For consumer-facing brands, recurring subscriptions stacked with owned-pharmacy fulfillment produce the strongest unit economics, as Hims and Ro demonstrate. The most defensible telehealth businesses combine models: a subscription for retention, pharmacy for margin, and either payer contracts or cash-pay for reach. Single-model, per-visit businesses are the easiest to launch but hardest to scale profitably.

Can I build my own telehealth app — and how much will it cost?

Yes. The core technology — secure video, messaging, scheduling, e-prescribing hooks, provider marketplaces, and subscription or cash-pay billing — is well-understood and reusable. With a white-label build from Make An App Like, a launch-ready telehealth platform ships in 14-30 days for roughly $4,500-$18,000, versus 6-12 months and far more for a from-scratch in-house effort. The larger cost is not software; it is clinician recruitment, multi-state licensure, and HIPAA-grade compliance. Budget for those from day one, because they, not the app, determine whether you can actually deliver care.

What's included in your white-label telehealth clone?

A white-label telehealth build from Make An App Like includes the complete source code deployed on your infrastructure and branded as your platform: HIPAA-ready video and secure messaging, patient and provider apps for iOS, Android, and web, appointment scheduling, e-prescribing and pharmacy integration hooks, cash-pay and subscription billing, and admin plus clinician dashboards. You own the code outright — no per-seat licensing lock-in. We hand off with documentation and deployment support so your team can extend it, add specialties, or integrate an EHR. The clinical, licensure, and compliance layers are yours to operate, and we scope those with you during the build.

Will AI reshape the telehealth app market by 2030?

Almost certainly, but at the intake and operations layer before the diagnosis layer. AI is already lowering the cost of triage — K Health's symptom assistant is the clearest example — and by 2030 expect AI to handle intake, documentation, follow-up messaging, and care-gap detection across most platforms, freeing scarce clinicians for the visits that need them. Autonomous diagnosis will stay tightly governed by regulators and liability. The winners will use AI to expand clinician capacity and cut per-visit cost, not to replace the clinician, since provider supply is the category's real bottleneck.